SEC Form 4 · accession 0001127602-18-023857
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Davide Molho
Officer — President & COO
Period of report
Jul 24, 2018
Accepted (ET)
Jul 25, 2018 · 6:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 24, 2018 | M | 5,474 | $59.41 | A | 27,553 | D | |
| Common Stock | Jul 24, 2018 | M | 8,375 | $73.70 | A | 35,928 | D | |
| Common Stock | Jul 24, 2018 | S | 18,773 | $125.00 | D | 17,155 | D | |
| Common Stock | holding | — | — | — | 40,748 | I | By Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $59.41 | Jul 24, 2018 | M | 5,474 | D | Feb 28, 2015 | Feb 28, 2021 | Common Stock | 5,474 | 0 | D |
| Stock Options (Right to Buy) | $73.70 | Jul 24, 2018 | M | 8,375 | D | Feb 26, 2017 | Feb 26, 2021 | Common Stock | 8,375 | 16,749 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.